期刊文献+

新诊断的严重高血糖2型糖尿病患者胰岛素治疗前后炎症递质的变化 被引量:1

The variation of inflammation mediators in patients with newly diagnosed severe hyperglycosemia after insuline treatment
下载PDF
导出
摘要 目的:观察严重高血糖2型糖尿病患者经胰岛素强化治疗前后炎症递质的变化情况,探讨高血糖与炎症的关系以及胰岛素的抗炎症作用。方法:入选20例空腹血糖(FBG)高于15 mmol/L或随机血糖大于30 mmol/L的2型糖尿病患者(严重高血糖组),进行胰岛素强化治疗,检测治疗前后血清脂联素(ANP)、IL-6、TNF-α水平,另选取血糖控制较好的一般糖尿病患者(空腹血糖≤7.0 mmol/L或餐后血糖≤10 mmol/L)(一般糖尿病组)及正常的健康人群各20例为对照组,比较三组治疗前的实验指标、严重高血糖组治疗前后实验结果,并比较严重高血糖组治疗后与一般糖尿病组及健康对照组的指标差异。结果:严重高血糖组ANP水平较一般糖尿病组高,IL-6、TNF-α水平健康对照组明显升高。严重高血糖组经胰岛素强化治疗后ANP水平升高接近于正常水平,而IL-6、TNF-α水平则有所下降,但未达到正常水平。结论:短期强化胰岛素治疗能快速改善2型糖尿病严重高血糖的炎症状态。 Objective:to reveal the relationship between hyperglycosemia,inflammation mediators and the anti-inflammatory effect of insulin intensive therapy in patients with newly diagnosed type 2 diabetes and severe hyperglycosemia.Methods:Twenty newly diagnosed type 2 diabetes patients with fasting plasma glucose(FPG) more than 15 mmol/L or random blood sugar(RBS)more than 30 mmol/L were treated with insuline intensive therapy(several hyperglycemia group).Their serum adiponectin,IL-6 and TNF-α were quantitatively measured at pre-and post-insulin treatment.Twenty common diabetic patients with well-controlled blood glucose(fasting plasma glucose≤7.0 mmol/L or past plasma glucose≤10 mmol/L)(general diabetes group)and 20 health patients(healty control group) were selected as control groups.Results:The serum level of adiponectin in several hyperlycemia group patients was higher than that of general diabetes group,while the levels of IL-6 and TNF-α in this group were obviously higher than that in healty control group.After insuline intensive therapy of several hyperlycemia group,the serum level of adiponectin increased to nearly normal level,while the levels of IL-6 and TNF-α decreased but still at abnormal level.Conclusion:Short-term insuline intensive therapy can quickly improve the inflam-mation state of newly diagnosed type 2 diabetes patients with severe hyperglycosemia.
出处 《温州医学院学报》 CAS 2010年第6期567-570,共4页 Journal of Wenzhou Medical College
基金 温州市科技局科研基金资助项目(Y20060215)
关键词 糖尿病 2型 胰岛素 治疗 炎症递质 diabetes type 2 insuline therapy mediators of inflammation
  • 相关文献

参考文献15

  • 1Pickup JC,Chusney GC,Thomas SM,et al.Plasma intereukin-6,tumor necrosis factor alpha and blood cytokine production in type 2 diabetes[J].Life Sci,2000,67(3):291300.
  • 2Leinonen E,Hurt-Camejo E,Wiklund O,et al.Insuline resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes[J].At herosclerosis,2003,166(2):387-394.
  • 3Iikova H,Glaser B,Tunckale A,et al.Induction of long term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment[J].Diabetes Care,1997,20(9):1353-1356.
  • 4李延兵,翁建平,许雯,陈小华,廖志红,姚斌,邓婉萍,欧香忠,胡国亮.短期持续胰岛素输注治疗对初诊2型糖尿病患者胰岛β细胞功能的影响[J].中国糖尿病杂志,2003,11(1):10-15. 被引量:777
  • 5Ryan E,Lmes S,Wallace C.Short-term intensive insulin therapy in newly diagnosed type 2 diabetic patients is assoiated with improvement of β-cell function[J].Diabetes,2004,27(1):2597.
  • 6祝方,纪立农,韩学尧,朱宇,张红杰,周翔海,陈静,蔡晓陵,张明霞.短期胰岛素强化治疗诱导初诊2型糖尿病患者血糖长期良好控制的临床试验[J].中国糖尿病杂志,2003,11(1):5-9. 被引量:856
  • 7Lindsay RS,Funahashi T,Hanson RL,et al,Adiponectin and development of type 2 diabetes in the Pima Indian population[J].Lancet,2002,360(9326):57-58.
  • 8Lappas M,Permezel M,Rice GE.Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via NF-κB,PPAR-γ and ERK 1/2[J].Endocrinology,2005,146(8):3334-3342.
  • 9Ajuwon KM,Spuriock ME.Adipocnectin inhibits LPS-induced NF-κB,acfivation and IL-6 production and increases PPAR-γ2 expression in adipocytes[J].Am J Physiol Regul Inter Comp Physiol,2005,288(5):R1220-R1225.
  • 10Delaigle AM,Jonas JC,Bauche IB,et al.Induction of adiponectin in skeletal muscle by inflammatory cytokines:in vivo and in vitro studies[J].Endocrinology,2004,145(12):5589-5597.

二级参考文献16

  • 1Weyer. Dificiency in AIR predict IGT and Type 2 diabetes. Diabetes Care, 2001,24 : 89-94.
  • 2Haffner SM, Miettinen H, Gaskill SP, et al. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes, 1995,44: 1386-1391.
  • 3Bruce DG, Chisholm DJ, Leonare H, et al. Physiological importance of deficiency in early prandial insulin secretion in non-in-sulin-dependent diabetes. Diabetes, 1988,37: 736-743.
  • 4Bruttomesso D, Pianta A, Mari A, et al. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes, 1999,48: 99-105.
  • 5Ilkova H, glaser B, Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care, 1997,20:1353-1356.
  • 6Walton C, Godsland IF, Proudler AJ, et al. Effect of body mass index and fat distribution on insulin sensitivity, secretion, and clearance in nonobese healthy men. J Clin Endocrinol Metab,1992,75: 170-175.
  • 7Purrello F, Rabuazza AM. Metabolic factors that affect betacell function and survival. Diabet Nutr Metab, 2000, 13: 84-91.
  • 8Sivitz WI. Lipotoxieity and glueotoxieity in type 2 diabetes. Effects on development and progression. Postgrad Med, 2001,109: 55-59,63-64.
  • 9Lenhard M J, Reeves GD. Continous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med,2001,161: 2293-2300.
  • 10Dupuy O, Mayaudon H, Palou M, et al. Optimized transient insulin infusion in uneontrolled type 2 Diabetes : Evaluation of a pragmatie attitude. Diabet Med, 2000,26 : 371-375.

共引文献1316

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部